title: [Late postpartum eclampsia].
abstract: A 36-year-old woman, who had given birth once before, had an eclamptic epileptic seizure eight days after caesarean delivery of healthy premature twins. Severe headache and loss of vision, leading to blindness, had not been recognised as prodromal signs by the healthcare professionals involved. Thereafter, she suffered a generalised epileptic seizure with tongue bite. She recovered fully after treatment with magnesium sulphate and nifedipine. Eclampsia is a severe condition with high rates of maternal complications, such as abruptio placentae, disseminated intravascular coagulation, neurological problems, pulmonary oedema, acute renal insufficiency and even death. Recognition of prodromal symptoms like headache, visual disturbances and upper abdominal pain is of the utmost importance. Magnesium sulphate intravenously is the treatment of choice. About 25% of the cases of postpartum eclampsia develop 2-28 days after delivery. A history of pre-eclampsia before or during the delivery is often absent. There is a relative increase in the incidence of late postpartum eclampsia, possibly because of misinterpretation ofprodromal symptoms, as illustrated by this case report. Every physician should be able to recognise the symptoms of pre-eclampsia and be aware of the possible consequences.
authors.affiliation: Academisch Medisch Centrum/Universiteit van Amsterdam, afd. Verloskunde en Gynaecologie, Meibergdreefg, 1105 AZ Amsterdam.
authors.forename: J M
authors.initials: JM
authors.lastname: van Weert
authors.forename: P J
authors.initials: PJ
authors.lastname: Hajenius
authors.forename: E
authors.initials: E
authors.lastname: Richard
authors.forename: H
authors.initials: H
authors.lastname: Wolf
authors.forename: O P
authors.initials: OP
authors.lastname: Bleker
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D002585:Cesarean Section; D004461:Eclampsia / Q000175:diagnosis* / Q000517:prevention & control; D005260:Female; D006261:Headache; D006801:Humans; D008278:Magnesium Sulfate / Q000627:therapeutic use*; D049590:Postpartum Period; D011247:Pregnancy; D011256:Pregnancy Outcome; D011272:Pregnancy, Multiple; D014786:Vision Disorders
chemical_list: D000927:Anticonvulsants; D008278:Magnesium Sulfate